Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.

Kovarova M, Council OD, Date AA, Long JM, Nochi T, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog. 2015 Aug; 11(8):e1005075.

View in: PubMed

subject areas

Animals
Anti-HIV Agents
Chromatography, High Pressure Liquid
Disease Models, Animal
Hela Cells
HIV Infections
Humans
Mice
Nanoparticles
Vaginal Creams, Foams, and Jellies

authors with profiles

Abhijit Date, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support